BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Advanced BioNutrition Corporation Receives MIPS Grant For Probiotic Study In Salmon


10/19/2005 5:10:09 PM

COLUMBIA, Md.--(BUSINESS WIRE)--Feb. 17, 2004--Advanced BioNutrition Corp. (ABN), a leader in developing functional nutrition technology to improve animal health and human nutrition, announced that it has received a $184,000 award from the MIPS (Maryland Industrial Partnerships) program to support a study on the use of probiotics to replace antibiotics for disease prevention in salmon. Fish and shrimp diseases around the world cause billions of dollars in losses each year in the aquaculture industry, and overuse of antibiotics leads to the development of antibiotic-resistant bacteria.

"The work we are conducting under this MIPS grant fits exactly within ABN's mission of developing safe, healthy and sustainable solutions to problems in the aquaculture and agriculture industries," said David J. Kyle, president and CEO of ABN.

ABN's novel microencapsulation technology allows delivery of probiotics ("friendly" bacteria) directly to the site of activity in the animal gut, where they prevent the growth of pathogenic bacteria.

ABN will deliver bacteria that are safe and widely used in human applications to juvenile salmon to prevent disease. Such a probiotic approach could provide better growth and survival, while alleviating the need for antibiotic treatment.

Research under this project, titled "Selective Administration of Non-Dairy Derived Lactic Acid Bacteria to Pre-Smolting Atlantic Salmon," will be conducted by Dr. Steven G. Hughes of the University of Maryland Eastern Shore and Dr. Moti Harel of ABN.

About MIPS

MIPS, a program of the A. James Clark School of Engineering's Maryland Technology Enterprise Institute (MTECH), enables technology commercialization in Maryland through jointly funded university-company research and development projects. For more information about MIPS, please visit http://www.mips.umd.edu.

About ABN

Advanced BioNutrition is a leader in developing functional nutrition technology to improve animal health and human nutrition. The company is headquartered in Columbia, MD. www.abn-corp.com.

--------------------------------------------------------------------------------

Contact:
Advanced BioNutrition Corp., Columbia
Al Cunniff, 410-730-8600

--------------------------------------------------------------------------------
Source: Advanced BioNutrition Corp.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES